The End: Revealing the Uniqueness of Individual Cells through the Lens of Mass Cytometry

终结篇:透过质谱流式细胞术揭示单个细胞的独特性

阅读:1

Abstract

Classical four-color fluorescence flow cytometry helped define the major cell subsets of the immune system that we understand today (i.e. T-cells, B-cells, macrophages). Machines with eight or more colors brought characterization of rare immune subsets and stem cells. With intracellular staining, higher parameter measurements lead to examination of regulatory signaling networks and patient stratification with clinical outcomes. However, this progression has now been stymied by the limits of fluorescence spectral overlap considerations in fluorophore-based tagging methods. Now, mass cytometry (CyTOF) offers examination of 30–50 parameters without fluorescent agents or interference from spectral overlap. Essentially, heavy metal isotopes as reporters replace fluorophores. By then exploiting the resolution, sensitivity, and dynamic range of elemental mass spectrometry, on a time-scale that allows the measurement of 1000 individual cells per second, this device offers a much-simplified alternative for ultra-high content cytometric analysis. Using mass cytometry (Science 2011) combined with novel single-cell visualization methods (SPADE Nature Biotechnology 2011) we examine healthy human bone marrow, measuring 34 parameters simultaneously in single cells (binding of 31 antibodies, viability, DNA content, and relative cell size). The signaling behavior of most cell subsets spanning a hematopoietic hierarchy defined by this profiling was monitored with 18 simultaneous functional markers and a battery of ex vivo stimuli and inhibitors. We will also provide examples of how high dimensional mass cytometry analysis can reveal previously unappreciated levels of organization in virus-specific memory T cell compartments (Immunity 2012), and massively multiplexed single-cells kinase inhibitor profiles on primary samples (Nature Biotechnology 2012). Together, these collective works expose unappreciated layers of human hematopoietic organization, and provide an opportunity to reevaluate diseases and pharmacological therapeutics as specific perturbations to this inherent order.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。